This tender is from the country of Latvia in Europe region. The tender was published by Nacionālais veselības dienests on 24 Jan 2025 for Development of a unified criteria model for the development of a drug purchase reimbursement system and audit of the list of reimbursed drugs for oncology diagnoses. The last date to submit your bid for this tender was 26 Feb 2025. This tender is for the companies specializing in Oncology and similar sectors.
*The deadline for this tender has passed.
Tender Organisation:
Nacionālais veselības dienests
Tender Sector:
Tender Service:
Worldwide
Tender Region:
Tender Country:
Tender CPV:
33100003 : Oncology
Tender Document Type:
Tender Notice
Tender Description:
Development of a unified criteria model for the development of a drug purchase reimbursement system and audit of the list of reimbursed drugs for oncology diagnoses
Tender Bidding Type:
Tender Notice No:
Tender Document:
Looking for more tenders like this one in Oncology? With over 70 million global procurement opportunities and new tenders added daily, Tender Impulse is your gateway to international and local contracting success. Whether you're targeting the Healthcare & Medical sector in Latvia, or expanding across regions, we provide live, accurate, and relevant updates every day.
Our platform sources tenders from:
Every day, we add hundreds of new RFPs, RFQs, EOIs, and contract awards across multiple sectors and geographies. This tender from Latvia is just a sample of what's available right now.
Tender Impulse covers:
Each listing is categorized using CPV codes like 33100003, enabling precise filtering. Search by:
While you're viewing a tender in Latvia, Tender Impulse offers access to tenders across:
Tender Impulse provides more than listings:
Thousands of new tenders are added daily-across countries, sectors, and CPV codes. With Tender Impulse, you gain strategic insight, timely alerts, and a competitive edge.
Start your free trial to unlock tenders customized to your Healthcare & Medical, Latvia, and Oncology categories.